002581 Shandong Sinobioway Biomedicine
- 12.86
- -0.37-2.80%
Shandong Sinobioway Biomedicine News
Unnamed Medicine: Announcement on the By-election of Independent Directors of the 5th Board of Directors and the Adjustment of Members of the Special Committee of the Board
Unnamed Pharmaceuticals: Notice on Convening the Fourth Extraordinary General Meeting of Shareholders in 2024
Unnamed Medicine: Independent Directors\' Open Call for Delegated Voting Rights Report
Unnamed Pharmaceuticals: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Unnamed Medicine: Legal Opinion of Zhejiang Tianze (Shenzhen) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Shandong Weiming Biomedical Co., Ltd.
Unnamed Pharmaceuticals: Announcement on Election of Staff Representative Supervisors of the Fifth Board of Supervisors and Election of the Chairman of the Fifth Board of Supervisors
Unnamed Pharmaceuticals: Progress Notice on Revising the “Articles of Association” of the participating company Beijing Kexing Biological Products Co., Ltd.
Unnamed Pharmaceuticals: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Unnamed Pharmaceuticals: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Unnamed Medicine: Legal Opinion of Zhejiang Tianze (Shenzhen) Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Shandong Weiming Biomedical Co., Ltd.
Unnamed Pharmaceuticals: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Unnamed Pharmaceuticals: Announcement on amending the “Articles of Association” of the participating company Beijing Kexing Biological Products Co., Ltd.
Unnamed Pharmaceuticals: Half-year summary table of non-operating capital usage and other related capital transactions
Unnamed Pharmaceuticals: 2024 Semi-Annual Financial Report
Unnamed Pharmaceuticals: Announcement on the Appointment of a Secretary of the Board
Unnamed Pharmaceuticals: Announcement on the Resignation of the Company\'s Board Secretary
Shandong Sinobioway Biomedicine: Announcement on the Progress of Completing the Internal Transfer of Equity and Business Registration Changes of Subsidiaries.
Shandong Sinobioway Biomedicine: Notice on changing the registered address and business scope of the subsidiary and amending the subsidiary's “Articles of Association”
Shandong Sinobioway Biomedicine: Announcement on the withdrawal of the M&A fund
Shandong Sinobioway Biomedicine: Announcement on the resignation of the company's senior management
No Data
